Vanguard Group’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-405,474
| Closed | -$251K | – | 4197 |
|
|
2018
Q4 | $251K | Sell |
405,474
-809,667
| -67% | -$501K | ﹤0.01% | 3860 |
|
|
2018
Q3 | $1.58M | Buy |
1,215,141
+1,800
| +0.1% | +$2.34K | ﹤0.01% | 3603 |
|
|
2018
Q2 | $1.64M | Sell |
1,213,341
-86,622
| -7% | -$117K | ﹤0.01% | 3559 |
|
|
2018
Q1 | $1.89M | Buy |
1,299,963
+440,703
| +51% | +$639K | ﹤0.01% | 3477 |
|
|
2017
Q4 | $1.93M | Buy |
859,260
+21,999
| +3% | +$49.5K | ﹤0.01% | 3427 |
|
|
2017
Q3 | $2.85M | Buy |
837,261
+98,726
| +13% | +$336K | ﹤0.01% | 3301 |
|
|
2017
Q2 | $2.62M | Sell |
738,535
-83,709
| -10% | -$297K | ﹤0.01% | 3300 |
|
|
2017
Q1 | $2.8M | Buy |
822,244
+106,488
| +15% | +$362K | ﹤0.01% | 3270 |
|
|
2016
Q4 | $3.29M | Buy |
715,756
+63,496
| +10% | +$292K | ﹤0.01% | 3194 |
|
|
2016
Q3 | $2.77M | Buy |
652,260
+159,999
| +33% | +$678K | ﹤0.01% | 3272 |
|
|
2016
Q2 | $1.18M | Buy |
492,261
+43,008
| +10% | +$103K | ﹤0.01% | 3561 |
|
|
2016
Q1 | $2.11M | Sell |
449,253
-1,500
| -0.3% | -$7.05K | ﹤0.01% | 3352 |
|
|
2015
Q4 | $1.77M | Sell |
450,753
-43,513
| -9% | -$171K | ﹤0.01% | 3440 |
|
|
2015
Q3 | $1.91M | Sell |
494,266
-194,666
| -28% | -$753K | ﹤0.01% | 3402 |
|
|
2015
Q2 | $3.17M | Buy |
688,932
+180,466
| +35% | +$830K | ﹤0.01% | 3215 |
|
|
2015
Q1 | $3.43M | Buy |
+508,466
| New | +$3.43M | ﹤0.01% | 3182 |
|